The Pharmacology of p-Aminopropiophenone in the Detoxification of Cyanide
Abstract
PAPP is effective as a pretreatment antidote to cyanide when used by single-dose administration. Further experiments need to be performed to establish a lack of toxicity of PAPP in multiple-dose experiments. Possible chronic hematological and genotoxic effects of PAPP may limit its development in repeated chronic treatment. Combination therapy of a prophylactic sulfur donor with a low dose of a safer prophylactic aminophenone (e.g., PAOP or p- aminoheptanoylphenone or their N-hydroxy metabolites) may provide more efficacious protection against cyanide than PAPP. This combination could allow for a reduction in the dosage of MetHb formers that would reduce the chance of unwanted side effects of the employed therapeutic compounds.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 01, 1992
- Accession Number
- ADA270793
Entities
People
- Robert F. Fricke
- Steven I. Baskin
Organizations
- United States Army Medical Research Institute of Chemical Defense